Soligenix, Inc. (SNGX)
NASDAQ: SNGX · Real-Time Price · USD
0.3210
+0.0010 (0.31%)
At close: Nov 13, 2026, 4:00 PM EST
0.3146
-0.0064 (-1.99%)
After-hours: Nov 13, 2026, 7:38 PM EST
Soligenix Market Cap
Soligenix has a market cap or net worth of $6.99 million as of November 13, 2026. It is the 43,265th most valuable company in the world and the 5,749th biggest in the United States. Its market cap has decreased by 51.14% in one year.
Market Cap
6.99M
Enterprise Value
-1.76M
1-Year Change
-51.14%
Global Rank
Country Rank
#5,749 United States
Category
ChartMarket Cap Chart
Since December 1, 1998, Soligenix's market cap has decreased from $24.80M to $6.99M, a decrease of -71.83%. That is a compound annual growth rate of -4.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 7.50M | -44.44% |
| Dec 31, 2025 | 13.50M | 98.53% |
| Dec 31, 2024 | 6.80M | -13.92% |
| Dec 29, 2023 | 7.90M | -59.49% |
| Dec 30, 2022 | 19.50M | -31.10% |
| Dec 31, 2021 | 28.30M | -25.92% |
| Dec 31, 2020 | 38.20M | 27.76% |
| Dec 31, 2019 | 29.90M | 96.71% |
| Dec 31, 2018 | 15.20M | -21.65% |
| Dec 29, 2017 | 19.40M | 128.24% |
| Dec 30, 2016 | 8.50M | -72.40% |
| Dec 31, 2015 | 30.80M | 42.59% |
| Dec 31, 2014 | 21.60M | -37.39% |
| Dec 31, 2013 | 34.50M | 414.93% |
| Dec 31, 2012 | 6.70M | 1.52% |
| Dec 30, 2011 | 6.60M | -83.90% |
| Dec 31, 2010 | 41.00M | -11.64% |
| Dec 31, 2009 | 46.40M | 660.66% |
| Dec 31, 2008 | 6.10M | -62.11% |
| Dec 31, 2007 | 16.10M | -2.42% |
| Dec 29, 2006 | 16.50M | 20.44% |
| Dec 30, 2005 | 13.70M | -49.07% |
| Dec 31, 2004 | 26.90M | -0.37% |
| Dec 31, 2003 | 27.00M | 167.33% |
| Dec 31, 2002 | 10.10M | -22.90% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immuron | 7.58M |
| CollPlant Biotechnologies | 7.38M |
| GT Biopharma | 7.15M |
| Theriva Biologics | 7.08M |
| Exicure | 7.07M |
| Ensysce Biosciences | 7.00M |
| Enveric Biosciences | 6.76M |
| Alzamend Neuro | 6.51M |